Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.010
-0.030 (-2.88%)
At close: Jul 31, 2026, 4:00 PM EDT
1.030
+0.020 (1.98%)
Pre-market: Aug 3, 2026, 9:03 AM EDT
Propanc Biopharma Employees
As of June 30, 2025, Propanc Biopharma had 2 total employees, including 1 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$9,646,588
Market Cap
2.30M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 2 | 0 | - | 1 | 1 |
| Jun 30, 2024 | 2 | 0 | - | 1 | 1 |
| Jun 30, 2023 | 2 | -1 | -33.33% | 1 | 1 |
| Jun 30, 2022 | 3 | 1 | 50.00% | 1 | 2 |
| Jun 30, 2021 | 2 | -1 | -33.33% | 1 | 1 |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Calidi Biotherapeutics | 29 |
| Virax Biolabs Group | 26 |
| Moleculin Biotech | 17 |
| Azitra | 13 |
| Decoy Therapeutics | 11 |
| Artelo Biosciences | 7 |
| GRI Bio | 4 |
| Creative Medical Technology Holdings | 4 |
PPCB News
- 13 days ago - Propanc Biopharma Publishes Evaluation of Recombinant Trypsinogen & Chymotrypsinogen in Peer Reviewed Journal - GlobeNewsWire
- 16 days ago - Propanc Biopharma registers to sell 2.5M shares of common stock for holders - TheFly
- 27 days ago - Propanc Biopharma signs MOU with Avance Clinical for PRP clinical trial - TheFly
- 27 days ago - Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd - GlobeNewsWire
- 4 weeks ago - Propanc Biopharma initiates share repurchase program - TheFly
- 4 weeks ago - Propanc Biopharma Initiates $5.0 Million Share Repurchase Program - GlobeNewsWire
- 6 weeks ago - Propanc CEO visits European manufacturer ahead of drug production plan - TheFly
- 6 weeks ago - Propanc Biopharma's CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study - GlobeNewsWire